To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults
Clinical trial NCT02361866 · COMPLETED
Trial details
- NCT number
- NCT02361866
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-09-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.